Friday, March 12, 2021

Several EU countries suspend AstraZeneca batches due to blood clotting fears

At least five European countries have suspended use of the Oxford-AstraZeneca Covid-19 vaccine amid reports of blood clotting in some people who've received it. 

The EU's health regulator says it is reviewing the incidents but suggests there was no "specific link" between blood clotting and the vaccine. 

Lucy Hough has more from Brussels. 

IN: Trouble
OUT: SOC
DUR: 0:41